Amanote Research
Register
Sign In
Impact of Pretransplant Comorbidities on Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Hematopoietic SCT for Patients With High-Risk Myelodysplastic Syndrome and AML
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2009.236
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
September 21, 2009
Authors
Z Y Lim
W Ingram
R Brand
A Ho
M Kenyon
S Devereux
J Marsh
G J Mufti
A Pagliuca
Publisher
Springer Science and Business Media LLC
Related search
Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML
Bone Marrow Transplantation
Transplantation
Hematology
Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome After Allogeneic Hematopoietic Cell Transplantation With Reduced Intensity Conditioning
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML
Bone Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Chronic GVHD Induced GVL Effect After Unmanipulated Haploidentical Hematopoietic SCT for AML and Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Mucous Membrane Pemphigoid Following Reduced Intensity Conditioning Allogeneic Haematopoietic SCT for Biphenotypic Leukaemia
Bone Marrow Transplantation
Transplantation
Hematology
No Evidence of Impact of Maraviroc on Outcome After Allogeneic Hematopoietic Stem Cell Transplant With Reduced Intensity Conditioning (RIC)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia
Cancer Control
Medicine
Oncology
Hematology
Pre-Transplant MRD Predicts Outcome Following Reduced-Intensity and Myeloablative Allogeneic Hemopoietic SCT in AML
Bone Marrow Transplantation
Transplantation
Hematology